http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0153274-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-0083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C35-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C35-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
filingDate 1985-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1990-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1990-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0153274-B1
titleOfInvention Carbacyclines, process for their preparation and their use as medicines
abstract Carbacyclins of Formula I <IMAGE> (I) wherein R1 is an alkyl, cycloalkyl, aryl, aralkyl, or heterocyclic group, Y is a keto group or a hydroxymethylene group, X is a -CH2- group or an oxygen atom, A is a -CH2-CH2-, a trans-CH=CH- or a -C 3BOND C- group, W is a hydroxymethylene group or a <IMAGE> D is the group <IMAGE> a straight-chain or branched, saturated alkylene group or unsaturated alkylene group of up to 5 carbon atoms which can optionally be substituted by 1-2 fluorine atoms, n is 1, 2 or 3, E is a direct bond, a -C 3BOND C- group or a -CR4=CR5- group wherein R4 is hydrogen or an alkyl group and R5 is hydrogen, halogen or an alkyl group, R2 is an alkyl, cycloalkyl, aryl, or heterocyclic group, and R3 is a hydroxy group, are valuable, e.g., as cytoprotective agents.
priorityDate 1984-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724141

Total number of triples: 31.